Nanobiotix S.A. (EPA: NANO)

Nanobiotix Balance Sheet

Financials in millions EUR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Cash & Equivalents	88.74	88.74	115.5	49.3	80.47	106.81
Cash & Short-Term Investments	88.74	88.74	115.5	49.3	80.47	106.81
Cash Growth	-23.17%	-23.17%	134.27%	-38.73%	-24.66%	-12.75%
Accounts Receivable	49.59	49.59	59.9	61.08	36.33	50.94
Other Receivables	20.24	20.24	28.34	24.39	23.62	26.66
Receivables	69.83	69.83	88.23	85.48	59.95	77.59
Inventory	190.54	190.54	196.17	182.22	179.95	183.59
Prepaid Expenses	4.57	4.57	4.52	3.68	4.52	4.05
Other Current Assets	39.79	39.79	26.14	26.62	28.96	29.92
Total Current Assets	393.47	393.47	430.56	347.3	353.85	401.96
Property, Plant & Equipment	169.93	169.93	163.38	169.17	194.45	221.14
Long-Term Investments	2.12	2.12	-0.61	1.39	2.63	2.67
Other Intangible Assets	56.49	56.49	53.76	55.43	46.19	65.22
Long-Term Deferred Tax Assets	11.43	11.43	1.56	11.2	7.01	20.37
Long-Term Deferred Charges	43.04	43.04	47.24	46.38	55.15	35.32
Other Long-Term Assets	2.87	2.87	4.02	4	12.83	4.05
Total Assets	681.54	681.54	701.95	636.79	672.11	752.31
Accounts Payable	85.57	85.57	81.69	85.63	43.27	89.49
Accrued Expenses	26.02	26.02	26.62	28.91	31.81	23.48
Short-Term Debt	21.1	21.1	11.61	16.16	18.93	40.13
Current Portion of Long-Term Debt	18.1	18.1	33.11	147.24	126.57	64.05
Current Portion of Leases	10.73	10.73	9.69	13.33	16.14	16.95
Current Income Taxes Payable	9.09	9.09	18.23	12.13	9.11	7.82
Current Unearned Revenue	88.43	88.43	52.77	41.56	35.7	24.97
Other Current Liabilities	6.71	6.71	12.02	6.45	5.65	7.46
Total Current Liabilities	265.75	265.75	245.74	351.41	287.18	274.34
Long-Term Debt	317.13	317.13	340.42	190.09	226.21	239.69
Long-Term Leases	17.57	17.57	15.1	27.85	40.56	45.58
Long-Term Deferred Tax Liabilities	0.16	0.16	0.92	10.9	7.44	22.08
Other Long-Term Liabilities	23.19	23.19	29.83	17.23	23.44	30.3
Total Liabilities	623.81	623.81	632	599.48	587.42	613.76
Common Stock	4.97	4.97	4.97	3.82	3.82	3.82
Additional Paid-In Capital	39.74	39.74	170.81	118.46	118.46	118.46
Retained Earnings	-12.23	-12.23	-18.07	-43.09	-57.15	-55.47
Treasury Stock	-5.02	-5.02	-5.5	-5.37	-5.29	-5.41
Comprensive Income & Other	30.28	30.28	-82.25	-36.54	24.79	77.05
Total Common Equity	57.73	57.73	69.96	37.28	84.63	138.46
Minority Interest	-	-	-0.01	0.02	0.06	0.09
Shareholders' Equity	57.73	57.73	69.95	37.3	84.69	138.55
Total Liabilities & Equity	681.54	681.54	701.95	636.79	672.11	752.31
Total Debt	384.63	384.63	409.92	394.66	428.4	406.39
Net Cash (Debt)	-295.89	-295.89	-294.42	-345.36	-347.93	-299.58
Net Cash Per Share	-7.23	-7.23	-7.64	-11.00	-11.08	-9.54
Filing Date Shares Outstanding	40.94	40.94	40.93	31.4	31.41	31.4
Total Common Shares Outstanding	40.94	40.94	40.93	31.4	31.41	31.4
Working Capital	127.72	127.72	184.82	-4.11	66.67	127.63
Book Value Per Share	1.41	1.41	1.71	1.19	2.69	4.41
Tangible Book Value	1.24	1.24	16.2	-18.15	38.44	73.24
Tangible Book Value Per Share	0.03	0.03	0.40	-0.58	1.22	2.33
Land	4.55	4.55	4.52	5.86	5.67	5.65
Buildings	81.96	81.96	78.45	80.63	78.19	78.31
Machinery	239.23	239.23	212.5	191.02	183.21	177.49
Construction In Progress	9.69	9.69	14.08	12.28	9.18	14.68

Source: S&P Capital IQ. Standard template. Financial Sources.